The approval of the oral Wegovy pill has set a new standard for patients in Texas who prefer this method over injections
Why GLP-1 Agonists May Not Be Safe for People with Type 1 Diabetes Eric Han Feb 23 4 min read GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza), and tirzepatide (Mounjaro, Zepbound) have dramatically improved treatment options for Type 2 diabetes and obesity
However, like any substance used therapeutically, potential side effects can occur
Iron chelators such as DFO (100 M) have been shown to downregulate TFR1 and reduce erastin-induced ferroptosis in SH-SY5Y dopaminergic neurons (Hadzhieva et al., 2013
Pregnant or breastfeeding individuals should also not use it
Manufacturers also offer discounts directly, so be sure to search around for the best deal when shopping